CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send AVKARE Inc. to request your refund or repair — edit it as you like.
Subject: Recall D-1044-2019 — AVKARE Inc. AVKARE Inc. recalls Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose bo Hello, I own a AVKARE Inc. recalls Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, that is covered by recall D-1044-2019 from AVKARE Inc.. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
